u/ImaginationRoutine96 · 356d agono track record yet
This $2 biotech might cure Parkinson’s and save Medicare billions. (Ticker: $GANX)
GANX, a $70M microcap, is developing a potential disease-modifying Parkinson's therapy showing early clinical success. Biomarker data due in 4–6 weeks could confirm blood–brain barrier penetration, α-synuclein reduction, and GCase activation; a successful readout or partnership announcement could trigger acquisition-level valuations ($1–$2B) or strategic deals, driving stock to $10–$15/share.
At post $2.49Now $1.13-54.6% since postedas of Oct 30, 4:45 PM ET
1d—
3d+18.5%
1w+13.7%
1m+62.7%
3m-29.7%
6m-26.9%
1y—